Table 5.
Title of study | Main findings | Reference |
---|---|---|
Noninvasive Brain Stimulation: The Potential for Use in the Rehabilitation of Pediatric Acquired Brain Injury | NIBS may serve as a tool for pediatric neurorehabilitation, but many gaps in our knowledge must be filled before NIBS can be adopted as a clinical intervention | (Chung and Lo, 2015) |
Safety of noninvasive brain stimulation in children and adolescents | TMS and TES are safe modalities in children and adolescents | (Krishnan et al., 2015) |
Transcranial Direct Current Stimulation in Child and Adolescent Psychiatry | tDCS may be well tolerated and safe for children and adolescents with psychiatric and neurodevelopmental disorders, at present it is not possible to draw definite conclusions | (Muszkat et al., 2016) |
Transcranial direct current stimulation in children and adolescents: a comprehensive review | Overall, tDCS seems to be safe in pediatric population | (Palm et al., 2016) |
Noninvasive Brain Stimulation in Pediatric Attention-Deficit Hyperactivity Disorder (ADHD): A Review | The safety profile of tDCS is excellent and the main documented AEs are an itching sensation and skin redness under the electrode | (Rubio et al., 2016) |
The use of noninvasive brain stimulation in childhood psychiatric disorders: new diagnostic and therapeutic opportunities and challenges | Although the utilization of TMS and tDCS remains limited in children, there is enough evidence for their rational, safe use in this population | (Rubio-Morell et al., 2011) |
Transcranial Direct Current Stimulation in Epilepsy | Induce suppression of epileptiform activity | (San-Juan et al., 2015) |
Transcranial direct current stimulation: a remediation tool for the treatment of childhood congenital dyslexia? | The studies provide preliminary evidence in support for a therapeutic potential of non-invasive stimulation techniques in children and adolescents | (Vicario and Nitsche, 2013) |
NIBS: noninvasive brain stimulation, tDCS: transcranial direct current stimulation, TMS: transcranial magnetic stimulation, AE: adverse event.